Therapeutic Area | MeSH |
---|---|
cardiovascular diseases | D002318 |
signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TENORMIN | Almatica Pharma | N-018240 RX | 1982-01-01 | 3 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TENORETIC 100 | Almatica Pharma | N-018760 RX | 1984-06-08 | 1 products, RLD, RS |
TENORETIC 50 | Almatica Pharma | N-018760 RX | 1984-06-08 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
atenolol | ANDA | 2024-02-14 |
atenolol and chlorthalidone | ANDA | 2024-01-16 |
atenolol scopolamine | unapproved drug other | 2014-10-15 |
tenoretic | New Drug Application | 2023-08-31 |
tenormin | New Drug Application | 2023-08-31 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 4 | 3 | 8 | 23 | 9 | 46 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | 7 | 2 | 2 | 11 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 4 | 5 | — | 9 |
Marfan syndrome | D008382 | Orphanet_558 | Q87.4 | — | 2 | 5 | 1 | — | 8 |
Healthy volunteers/patients | — | — | — | 2 | 1 | — | 1 | 3 | 7 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | 1 | 1 | 4 | 6 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | 1 | 2 | 2 | 5 |
Blood pressure | D001794 | EFO_0004325 | — | 1 | — | — | 3 | — | 4 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | 2 | 1 | 4 |
Heart failure | D006333 | HP_0001635 | I50 | — | — | 1 | 3 | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Left ventricular hypertrophy | D017379 | EFO_0003896 | — | — | — | 3 | — | — | 3 |
Neoplasms | D009369 | — | C80 | — | — | 1 | — | 1 | 2 |
Cerebral small vessel diseases | D059345 | — | — | — | — | 1 | — | — | 1 |
Mitral valve stenosis | D008946 | EFO_0007372 | — | — | — | 1 | — | — | 1 |
Renal dialysis | D006435 | EFO_0010690 | Z99.2 | — | — | 1 | — | — | 1 |
Cerebrovascular disorders | D002561 | EFO_0003763 | I60-I69 | — | — | 1 | — | — | 1 |
Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | 1 | — | — | 1 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 1 | — | — | 1 |
Hemangioma | D006391 | — | D18.0 | — | — | 1 | — | — | 1 |
Medication adherence | D055118 | EFO_0006344 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pheochromocytoma | D010673 | — | — | — | 1 | — | — | — | 1 |
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | 1 | — | — | — | 1 |
Migraine disorders | D008881 | EFO_0003821 | G43 | — | 1 | — | — | — | 1 |
Vestibular diseases | D015837 | EFO_0009691 | H81 | — | 1 | — | — | — | 1 |
Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | 1 | 1 | — | — | — | 1 |
Orthostatic intolerance | D054971 | — | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pre-eclampsia | D011225 | EFO_0000668 | O14 | 2 | — | — | — | — | 2 |
Morbid obesity | D009767 | EFO_0001074 | — | 1 | — | — | — | — | 1 |
Osteoporosis | D010024 | HP_0000939 | M81.0 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | — | — | 2 | 2 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Aneurysm | D000783 | HP_0002617 | I72.9 | — | — | — | — | 1 | 1 |
Cachexia | D002100 | HP_0004326 | R64 | — | — | — | — | 1 | 1 |
Prediabetic state | D011236 | EFO_1001121 | R73.03 | — | — | — | — | 1 | 1 |
Exercise test | D005080 | EFO_0004328 | — | — | — | — | — | 1 | 1 |
Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | — | — | — | 1 | 1 |
Orthognathic surgery | D057909 | — | — | — | — | — | — | 1 | 1 |
Pregnancy rate | D018873 | — | — | — | — | — | — | 1 | 1 |
Low cardiac output | D002303 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Atenolol |
INN | atenolol |
Description | Atenolol is an ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent. It has a role as a beta-adrenergic antagonist, an anti-arrhythmia drug, an antihypertensive agent, a sympatholytic agent, a xenobiotic and an environmental contaminant. It is a member of ethanolamines, a monocarboxylic acid amide and a propanolamine. |
Classification | Small molecule |
Drug class | beta-blockers (propranolol type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)NCC(O)COc1ccc(CC(N)=O)cc1 |
PDB | — |
CAS-ID | 29122-68-7 |
RxCUI | — |
ChEMBL ID | CHEMBL24 |
ChEBI ID | 2904 |
PubChem CID | 2249 |
DrugBank | DB00335 |
UNII ID | 50VV3VW0TI (ChemIDplus, GSRS) |